Evidence map›Paper›PMID 34016531›Full record

ReviewPaediatric respiratory reviews2021

Impact of non-pharmacological initiatives for COVID-19 on hospital admissions due to pediatric acute respiratory illnesses.

Sabrina Chiapinotto, Edgar E Sarria, Helena T Mocelin, João A B Lima, Rita Mattiello, Gilberto B Fischer

Open access · greenAbstract readReview
In one paragraph

Review in Paediatric respiratory reviews, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Epidemiological Characteristics and Trends of Scarlet Fever in Zhejiang Province of China: Population-Based Surveillance during 2004-2022.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Allergic diseases and immunodeficiencies in children, lessons learnt from COVID-19 pandemic by 2022: A statement from the EAACI-section on pediatrics.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2022
    Article
  18. Impact of COVID-19 mitigation strategies on asthma hospitalizations in Brazil.The journal of allergy and clinical immunology. Global · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Sabrina ChiapinottoPostgraduate Program in Pulmonology, UFRGS, Porto Alegre, Brazil.
Edgar E SarriaPediatric Pulmonology Section, Hospital da Criança Santo Antônio, Porto Alegre, Brazil.
Helena T MocelinPediatric Pulmonology Section, Hospital da Criança Santo Antônio, Porto Alegre, Brazil; Pediatrics Department, Federal University of Health Sciences of Porto Alegre, Brazil.
João A B LimaPediatric Pulmonology Section, Hospital da Criança Santo Antônio, Porto Alegre, Brazil; Porto Alegre City Health Department, Porto Alegre, Brazil.
Rita MattielloPontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil.
Gilberto B FischerPediatric Pulmonology Section, Hospital da Criança Santo Antônio, Porto Alegre, Brazil; Pediatrics Department, Federal University of Health Sciences of Porto Alegre, Brazil; Postgraduate Program in Pediatrics, UFCSPA, Porto Alegre, Brazil. Electronic address: gilbertobf@ufcspa.edu.br.
Hospital Nossa Senhora da Conceição · BRPontifícia Universidade Católica do Rio Grande do Sul · BRUniversidade Federal do Rio Grande do Sul · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionInterventions to deal with the COVID-19 pandemic may impact the burden of other respiratory diseases. The aim of this study is to analyze the impact of non-pharmacological initiatives (NPI) against COVID-19 on the number of hospitalizations due to pediatric acute respiratory illnesses (ARIs). MATERIAL AND

methodsThis is a retrospective analysis of pediatric hospitalizations in Porto Alegre, Brazil. We analyzed the monthly incidence of hospital admissions from 2018 to 2020 due to ARIs included in the study. The time series was divided into the period before introducing NPI (2018 and 2019), and the period when NPI were running (2020). We compared means between the years with Student's t-test. The Dickey-Fuller test was used for secular trend analysis. For seasonality, Fischer's G test was performed. Dynamic linear univariate and multivariate models were used to estimate the association between the predictors (the introduction of NPI, secular trend, and seasonality) and outcome (the incidence of ARI admissions). For the statistical analysis, the cut-off probability for rejecting the null hypothesis was defined as <5%.

resultsFrom 2018 to 2020, 10,109 hospital admissions were due to the respiratory causes included in this study. There was a significant decrease in 2020 in the mean incidence of the ARIs studied compared with 2018 and 2019. The number of hospitalizations due to respiratory diseases in children decreased by 64% for asthma and 93% for bronchiolitis. A secular trend of monthly admissions rates due to ARIs was only observed in the laryngotracheitis data (p = 0.485), but seasonality was detected in all analyses. According to the univariate and multivariate analysis, the introduction of NPI was associated with a decrease in the incidence of ARI admissions.

conclusionThere was a significant reduction in hospital admissions due to ARIs in children. Our data suggest a significant impact of NPI on reducing the spread of viruses associated with ARIs in children. These results support respiratory illness prevention strategies.

Indexed as

Acute DiseaseAdolescentBrazilChildChild, PreschoolCOVID-19HospitalizationHumansInfantInfant, NewbornMalePandemicsPneumonia, ViralRespiratory Tract InfectionsRetrospective StudiesSARS-CoV-2ChildrenCOVID-19HospitalizationLockdownRespiratory tract infections

Identifiers

PMID34016531
PMCPMC8074521
OpenAlexW3159043962

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.